Literature DB >> 8482428

Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients.

P Rossing1, E Hommel, U M Smidt, H H Parving.   

Abstract

To evaluate the impact of systemic blood pressure and albuminuria on the progression of diabetic nephropathy, we followed 41 IDDM patients with persistent albuminuria (> 300 mg/24 h) by measuring glomerular filtration rate (51Cr-EDTA technique), blood pressure, and albuminuria. None of the patients were taking drugs other than insulin. Arterial blood pressure, albuminuria, and blood glucose were measured four to eight times/yr, whereas glomerular filtration rate was determined twice yearly. During the median investigation period of 36 (15-66) mo, glomerular filtration rate decreased from 102 +/- 23 to 83 +/- 27 ml.min-1 x 1.73 m-2 (P < 0.001), albuminuria increased from 633 to 1435 micrograms/min (P < 0.001), and blood pressure rose from 133/85 +/- 10/9 to 149/93 +/- 8/11 mmHg (P < 0.001). Univariate analysis revealed a significant correlation between the rates of decline in glomerular filtration rate and diastolic blood pressure (r = 0.52, P < 0.01) and glomerular filtration rate and albuminuria (r = 0.34, P < 0.02). But stepwise multiple linear regression analysis only showed a significant correlation between the rate of decline in glomerular filtration rate and diastolic blood pressure (P < 0.01). In patients with diastolic blood pressure below the mean value of 89 mmHg, stepwise multiple regression analysis showed that albuminuria and not blood pressure was correlated significantly with rate of decline in glomerular filtration rate. Patients were stratified by average value of diastolic blood pressure measured during the investigation period.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8482428     DOI: 10.2337/diab.42.5.715

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  19 in total

Review 1.  Management of diabetic nephropathy.

Authors:  L Foggensteiner; S Mulroy; J Firth
Journal:  J R Soc Med       Date:  2001-05       Impact factor: 5.344

2.  Association of the pattern recognition molecule H-ficolin with incident microalbuminuria in an inception cohort of newly diagnosed type 1 diabetic patients: an 18 year follow-up study.

Authors:  Jakob A Østergaard; Steffen Thiel; Peter Hovind; Charlotte B Holt; Hans-Henrik Parving; Allan Flyvbjerg; Peter Rossing; Troels K Hansen
Journal:  Diabetologia       Date:  2014-07-28       Impact factor: 10.122

3.  Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005.

Authors:  P Rossing
Journal:  Diabetologia       Date:  2005-12-09       Impact factor: 10.122

Review 4.  Renoprotective role of ACE inhibitors in diabetic nephropathy.

Authors:  C E Mogensen
Journal:  Br Heart J       Date:  1994-09

Review 5.  The diabetic patient with hypertension.

Authors:  G P Leese; M W Savage; P D Chattington; J P Vora
Journal:  Postgrad Med J       Date:  1996-05       Impact factor: 2.401

6.  Calcium-channel blockers and the progression of renal disease.

Authors:  K A Griffin; A K Bidani
Journal:  Curr Hypertens Rep       Date:  1999-10       Impact factor: 5.369

7.  Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Nrupen A Bhavsar; Anna Köttgen; Josef Coresh; Brad C Astor
Journal:  Am J Kidney Dis       Date:  2012-04-28       Impact factor: 8.860

8.  Proteinuria as a predictor of disease progression in children with hypodysplastic nephropathy. Data from the Ital Kid Project.

Authors:  Gianluigi Ardissino; Sara Testa; Valeria Daccò; Sara Viganò; Emanuela Taioli; Aldo Claris-Appiani; Mirella Procaccio; Luigi Avolio; Antonio Ciofani; Luca Dello Strologo; Giovanni Montini
Journal:  Pediatr Nephrol       Date:  2003-12-13       Impact factor: 3.714

9.  Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy.

Authors:  Uzma F Mehdi; Beverley Adams-Huet; Philip Raskin; Gloria L Vega; Robert D Toto
Journal:  J Am Soc Nephrol       Date:  2009-11-19       Impact factor: 10.121

10.  Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment.

Authors:  P Rossing; E Hommel; U M Smidt; H H Parving
Journal:  Diabetologia       Date:  1994-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.